Primary Side Hybrid Reconfigurable Compensation for Wireless EV Charging With Constant Current/Constant Voltage Control
IEEE Access · 2024 · 12 · 149960-149976
DOI: 10.1109/access.2024.3478801 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Access, 2024. Verfasst von K. Arulvendhan und 5 weiteren Autor:innen. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Council of Scientific and Industrial Research (CSIR), India, under Extramural Research-II (EMR II) Research Scheme, King Abdullah City for Atomic and Renewable Energy, King Abdulaziz University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Council of Scientific and Industrial Research (CSIR), India, under Extramural Research-II (EMR II) Research Scheme
- King Abdullah City for Atomic and Renewable Energy
- King Abdulaziz University
- Deanship of Scientific Research at Northern Border University, Arar, Saudi Arabia
Zitieren
APA
Arulvendhan, K., Nagaratnam, S. K., Narayanamoorthi, R., Milyani, A. H., Alghamdi, S., & Alruwaili, M. (2024). Primary Side Hybrid Reconfigurable Compensation for Wireless EV Charging With Constant Current/Constant Voltage Control. IEEE Access, 12, 149960-149976. https://doi.org/10.1109/access.2024.3478801
Vancouver
Arulvendhan K, Nagaratnam SK, Narayanamoorthi R, Milyani AH, Alghamdi S, Alruwaili M. Primary Side Hybrid Reconfigurable Compensation for Wireless EV Charging With Constant Current/Constant Voltage Control. IEEE Access. 2024;12:149960-149976. doi:10.1109/access.2024.3478801
BibTeX
@article{Arulvendhan2024,
author = {Arulvendhan, K. and Nagaratnam, Srinivas Kandadai and Narayanamoorthi, R. and Milyani, Ahmad H. and Alghamdi, Sultan and Alruwaili, Mohammed},
title = {Primary Side Hybrid Reconfigurable Compensation for Wireless EV Charging With Constant Current/Constant Voltage Control},
journal = {IEEE Access},
year = {2024},
volume = {12},
pages = {149960--149976},
doi = {10.1109/access.2024.3478801}
}
EUVIMED